Skip to main content
. 2016 Dec 16;6(12):e510. doi: 10.1038/bcj.2016.115

Figure 2.

Figure 2

Association of individual mutations with each clinical subtype of AML defined by age, cytogenetics and WBC as described by odds ratio on a log10 scale. Blue indicates mutations that are >95% specific for primary AML and red indicates mutations that are >95% specific for secondary AML.